Implementation of Pharmaceutical Care Services for Patients with Hyperlipidemias by Independent Community Pharmacy Practitioners

Abstract

Pharmaceutical care may positively affect lipid values, quality of life, and patient satisfaction.

The General Practitioner–Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy

“…With little previous data available on expected changes in MAI the SF‐36 score was used to calculate the number of general practitioners required if each general practitioner enrolled 12 patients. Twelve patients were considered a manageable number of patients per pharmacist based the expected time requirements and on other studies [17–22] . The calculations were based on a clinically important change in SF‐36 score value being 10 units (physical function) and a standard deviation of 25 units, allowing for a clustering effect around the general practitioners with an intracluster correlation coefficient of 0.05, a level of significance of 0.05 and 80% power.…”

A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management<subtitle>The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</subtitle>

“…[46][47][48][49][50][51] The enhanced role of the pharmacist in preventive medicine has been advocated by the American Heart Association, 52 the British National Health Service, 53 a joint statement by the Canadian Medical Association and the Canadian Pharmacists' Association, 54 and others. 30,55,56 Pharmacists have successfully implemented preventive health programs in cholesterol management, [57][58][59][60][61] hypertension, 62 and other areas, 47,63 but often without comprehensive evaluation. Pharmacists may act as a link between the patient and the primary care physician, thus addressing many of the reported barriers to preventive care described by Hutchison et al 28 Project ImPACT was a nonrandomized observational study 61 of pharmacists' care of patients with hyperlipidemia carried out in 26 pharmacies that followed 397 patients for an average of 24.6 months.…”

The Short-Term Impact of a Continuing Education Program on Pharmacists' Knowledge and Attitudes Toward Diabetes

“…Pharmaceutical care has significantly reduced the occurrence of drug-related problems and fulfilled the desired outcomes of drug therapy in other diseases and conditions such as anticoagulation, hyperlipidemia, and asthma. [8][9][10][11][12][13] Studies have also shown that pharmacists' participation in the care of poorly controlled diabetic patients resulted in better outcomes. 14 However, pharmacists' participating in diabetic care are still not required to have CDE certification.…”